Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

RNA-seq03:21

RNA-seq

9.8K
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases. 
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
9.8K
Next-generation Sequencing03:00

Next-generation Sequencing

88.3K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
88.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genomic Medicine Sweden: Advancing precision medicine at the national level.

Journal of internal medicine·2026
Same author

Baseline plasma-informed circulating tumor DNA analyses comparing multiplex digital PCR and NGS for longitudinal monitoring in Hodgkin lymphoma.

Blood cancer journal·2026
Same author

High-Dose Methotrexate as CNS Prophylaxis in Ultra High-Risk Large B-Cell Lymphoma: An International Multicenter Analysis.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Stakeholders' perceptions of the synergy between intellectual property and open science: A cross-sectional survey.

Open research Europe·2026
Same author

Development and Validation of a Novel Conditional Event-Free Survival Tool in Diffuse Large B-Cell Lymphoma.

American journal of hematology·2026
Same author

Central nervous system involvement and relapse in adult acute lymphoblastic leukaemia-a population-based analysis in 2007-2022.

British journal of haematology·2026

Related Experiment Video

Updated: Jun 10, 2025

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER
14:06

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER

Published on: June 23, 2012

15.2K

Smart variant filtering - A blueprint solution for massively parallel sequencing-based variant analysis.

Orlinda Brahimllari1,2, Sandra Eloranta3, Patrik Georgii-Hemming4

  • 1MedTechLabs, BioClinicum, Karolinska University Hospital, Stockholm, Sweden.

Health Informatics Journal
|October 11, 2024
PubMed
Summary
This summary is machine-generated.

This study designed an AI-augmented system to streamline the clinical diagnosis of lymphoma by systematically filtering and interpreting genetic variants identified through massively parallel sequencing.

Keywords:
artificial intelligenceclinical decision makingmachine learningmassively parallel sequencingnext-generation sequencingvariant analysisvariant filtering

More Related Videos

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

33.7K
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.1K

Related Experiment Videos

Last Updated: Jun 10, 2025

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER
14:06

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER

Published on: June 23, 2012

15.2K
Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

33.7K
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.1K

Area of Science:

  • Genomics
  • Bioinformatics
  • Artificial Intelligence

Background:

  • Massively parallel sequencing generates complex genomic data for cancer patients.
  • Manual interpretation of genetic variants for clinical decision-making is labor-intensive.
  • Accurate identification of actionable variants is crucial for cancer diagnostics.

Purpose of the Study:

  • To design a systematic solution for variant filtering and interpretation in lymphoma clinical diagnostics.
  • To leverage artificial intelligence for improving the efficiency of genomic data analysis.

Main Methods:

  • A scoping review of variant filtering solutions was conducted.
  • Demonstrations and interviews with clinical specialists informed the solution blueprint.
  • Machine learning methods were integrated into the diagnostic decision-making process.

Main Results:

  • A blueprint for an AI-augmented system for genetic diagnostics was developed.
  • The system integrates algorithms, AI applications, software, and bioinformatics pipelines.
  • Validation interviews confirmed the blueprint's relevance across expert disciplines.

Conclusions:

  • An AI-augmented system is designed to predict pathogenic variants in lymphoma.
  • The system aids in classifying variants, but human oversight remains essential for accuracy.
  • Diagnosticians must validate AI classifications and make final pathogenic variant determinations.